Sustained release nitric oxide producing agents
CA 2338706 A1 · Owner: Kuhrts, Eric · Inventors: Kuhrts, Eric
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed are various sustained release pharmaceutical compositions that include an agent that enhances or modulates the endogenous production of nitric oxide or insulin in a mammal. Sustained release pharmaceutical compositions of L-arginine, its salts, peptides esters, and biological , equivalents, together with methods of using the compositions are included. Also included are sustained release pharmaceutical compositions of botanical extracts that modulate or enhance the production of nitric oxide or insulin, either alone or in combination with L-arginine or its biological equivalent.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 28, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 28, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 28, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.